Drugs
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwire) -- 11/09/12 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the third quarter and for the nine months ended September 30, 2012. I ...
PARSIPPANY, NJ: PARSIPPANY, NJ -- (Marketwire) -- 11/08/12 -- The Medicines Company (NASDAQ: MDCO) will present at the Jefferies Global Healthcare Conference on Wednesday, November 14th in London at 5:00 pm Greenwic ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwire) -- 11/08/12 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report third quarter 2012 financial results and 2012 outlook on Friday, N ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwire) -- 11/07/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:Patrick Machado, chief business and financial office ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 11/07/12 -- (NASDAQ: PATH), a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the centra ...
LYON, FRANCE: Conference Call With Management to Take Place at 8:30 AM EST on November 5, 2012 ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwire) -- 11/02/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss third quarter 2012 financial result ...
CARY, NC: CARY, NC -- (Marketwire) -- 11/01/12 -- Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday, November 8, 2012, to discuss its financial results for th ...
PALATINE, IL: PALATINE, IL -- (Marketwire) -- 11/01/12 -- Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating , today announced that the company plans to report financial resu ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 10/30/12 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, will report third quarter 2012 financial results after the NA ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 10/30/12 -- Theravance, Inc. (NASDAQ: THRX) reported today its financial results for the quarter ended September 30, 2012. Revenue for the third quarter of ...
LYON, FRANCE: LYON, FRANCE -- (Marketwire) -- 10/30/12 -- Flamel Technologies (NASDAQ: FLML) expects to release certain financial results for the third quarter of 2012, on Monday, November 5th, before the market o ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 10/24/12 -- Kadmon Corporation, LLC, today announced that the first patient has been dosed in a Phase 1b/2a study of KD020, a reversible tyrosine kinase inhibitor targ ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 10/23/12 -- NuPathe Inc. (NASDAQ: PATH), a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases o ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/19/12 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CNSX: FLU) announces the resignation of Mr. Yazan Al Homsi as ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/18/12 -- . (TSX VENTURE: SBM)(PINKSHEETS: SRBCF)(FRANKFURT: ZSB), an award-winning biotechnology company based in Vancouver, Canada and Rouen, France ...
LYON, FRANCE: LYON, FRANCE -- (Marketwire) -- 10/18/12 -- Flamel Technologies SA (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application ...
TORONTO, ONTARIO: Increasing demand from larger retailers allows for 35% expansion in capacity ...
